Apr 3, 2023Alpha Tau & JGH Announce Alpha Dart treatment of First Patient in Pancreatic Cancer Clinical Trial-First patient treated in the feasibility and safety study of intratumoral diffusing alpha radiation emitters for the treatment of...
Mar 30, 2023Alpha Tau Medical to Present at Jefferies Radiopharma Innovation SummitJERUSALEM, March 30, 2023 -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer of the...
Mar 12, 2023Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley BankJERUSALEM, March 12, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the “Company”) (NASDAQ: DRTS, DRTSW), the developer...
Mar 10, 2023Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update- Opened U.S. pivotal trial in recurrent cutaneous squamous cell carcinoma, which began enrolling patients in March - - Received Health...
Mar 9, 2023Treatment of 1st two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) TrialAlpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial -First...